Colloquium paper: uniquely human evolution of sialic acid genetics and biology.
Darwinian evolution of humans from our common ancestors with nonhuman primates involved many gene-environment interactions at the population level, and the resulting human-specific genetic changes must contribute to the "Human Condition." Recent data indicate that the biology of sialic acids (which directly involves less than 60 genes) shows more than 10 uniquely human genetic changes in comparison with our closest evolutionary relatives. Known outcomes are tissue-specific changes in abundant cell-surface glycans, changes in specificity and/or expression of multiple proteins that recognize these glycans, and novel pathogen regimes. Specific events include Alu-mediated inactivation of the CMAH gene, resulting in loss of synthesis of the Sia N-glycolylneuraminic acid (Neu5Gc) and increase in expression of the precursor N-acetylneuraminic acid (Neu5Ac); increased expression of alpha2-6-linked Sias (likely because of changed expression of ST6GALI); and multiple changes in SIGLEC genes encoding Sia-recognizing Ig-like lectins (Siglecs). The last includes binding specificity changes (in Siglecs -5, -7, -9, -11, and -12); expression pattern changes (in Siglecs -1, -5, -6, and -11); gene conversion (SIGLEC11); and deletion or pseudogenization (SIGLEC13, SIGLEC14, and SIGLEC16). A nongenetic outcome of the CMAH mutation is human metabolic incorporation of foreign dietary Neu5Gc, in the face of circulating anti-Neu5Gc antibodies, generating a novel "xeno-auto-antigen" situation. Taken together, these data suggest that both the genes associated with Sia biology and the related impacts of the environment comprise a relative "hot spot" of genetic and physiological changes in human evolution, with implications for uniquely human features both in health and disease.
Varki
Ajit
A
Center for Academic Research and Training in Anthropogeny, Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA. a1varki@ucsd.edu
D015703:Antigens, CD / Q000235:genetics; D015214:Antigens, Differentiation, Myelomonocytic / Q000235:genetics; D001120:Arginine; D004777:Environment; D005260:Female; D006801:Humans; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D008957:Models, Genetic; D019158:N-Acetylneuraminic Acid / Q000378:metabolism*; D011134:Polysaccharides / Q000378:metabolism; D011225:Pre-Eclampsia / Q000378:metabolism; D011247:Pregnancy; D011971:Receptors, Immunologic / Q000235:genetics; D063267:Sialic Acid Binding Ig-like Lectin 1; D063268:Sialic Acid Binding Ig-like Lectin 3
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D008562:Membrane Glycoproteins; D011134:Polysaccharides; D011971:Receptors, Immunologic; C571166:SIGLEC1 protein, human; D063267:Sialic Acid Binding Ig-like Lectin 1; D063268:Sialic Acid Binding Ig-like Lectin 3; D001120:Arginine; D019158:N-Acetylneuraminic Acid
Nature. 2007 Nov 1;450(7166):110-4
17934446
J Med Primatol. 2010 Feb;39(1):9-23
19900169
Mol Cell Biol. 2006 Feb;26(4):1549-57
16449664
Arch Intern Med. 2009 Mar 23;169(6):562-71
19307518
Hoppe Seylers Z Physiol Chem. 1984 Dec;365(12):1457-67
6526381
Mol Cell Biol. 2007 Jun;27(12):4340-6
17420276
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18936-41
19017806
Genome Res. 2000 Aug;10(8):1065-70
10958623
J Hum Evol. 2009 Oct;57(4):379-91
19732938
Mol Microbiol. 2003 Sep;49(5):1213-25
12940982
FEBS Lett. 2010 Feb 5;584(3):555-61
19945458
J Biol Chem. 2003 Nov 28;278(48):48245-50
14500706
Nature. 1970 Aug 8;227(5258):561-3
4913914
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14739-40
19717444
Curr Opin Biotechnol. 2009 Dec;20(6):673-7
19892543
Front Biosci. 2003 Sep 01;8:d1134-45
12957818
J Virol. 1998 Nov;72(11):9079-91
9765453
Nat Med. 1995 Oct;1(10):1009-16
7489355
Am J Phys Anthropol. 1998 Oct;107(2):187-98
9786333
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12819-24
16126901
Science. 1999 Apr 2;284(5411):65-71
10102822
Arthritis Rheum. 2008 Apr;58(4):1136-45
18383365
Am J Clin Nutr. 1999 Sep;70(3 Suppl):532S-538S
10479227
PLoS One. 2008 Apr 16;3(4):e1967
18414664
Evol Appl. 2009 Feb;2(1):101-12
25567850
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11736-41
12192086
J Immunol. 2005 Jul 1;175(1):228-36
15972653
Glycobiology. 2003 Aug;13(8):591-600
12672700
J Biol Chem. 2006 Sep 1;281(35):25689-702
16769723
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12045-50
14523234
Acta Histochem Suppl. 1990;40:35-8
2091044
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14902-7
19666593
Diabetes Care. 2004 Sep;27(9):2108-15
15333470
J Biol Chem. 2001 Oct 26;276(43):40282-7
11546777
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7390-7
7519775
Genome Res. 2005 Dec;15(12):1746-58
16339373
J Biol Chem. 2000 Mar 24;275(12):8633-40
10722703
Arch Biochem Biophys. 1989 Apr;270(1):391-7
2648997
J Virol. 2007 Dec;81(23):12846-58
17855525
Biochem Biophys Res Commun. 1977 Nov 21;79(2):388-95
412499
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13552-7
19666579
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7765-70
16682635
J Biol Chem. 2002 Jul 5;277(27):24466-74
11986327
Glycobiology. 2009 Aug;19(8):841-6
19369701
Virology. 1984 Oct 15;138(1):174-7
6208680
Proc Nutr Soc. 2008 Aug;67(3):253-6
18452640
Nat Genet. 2007 Jan;39(1):31-40
17159977
Glycobiology. 2007 Sep;17(9):922-31
17580316
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5267-70
11929971
J Biol Chem. 2004 Oct 8;279(41):43117-25
15292262
Endocrinology. 2009 Jan;150(1):452-62
18818296
Biochimie. 2001 Jul;83(7):623-34
11522391
Nat Rev Genet. 2008 Oct;9(10):749-63
18802414
J Exp Med. 2009 Aug 3;206(8):1691-9
19596804
J Biol Chem. 2005 Feb 11;280(6):4228-37
15557321
Blood. 2009 Apr 2;113(14):3333-6
19196661
J Immunol. 2010 Apr 15;184(8):4185-95
20231688
Cell. 2006 Sep 8;126(5):841-5
16959563
Glycobiology. 2008 Oct;18(10):818-30
18669916
Glycoconj J. 1997 Aug;14(5):601-9
9298693
Blood. 2009 Oct 22;114(17):3668-76
19704115
Kidney Int. 2009 Jul;76(2):140-4
19387473
Glycobiology. 2001 Aug;11(8):663-76
11479277
Eur J Immunol. 2008 Aug;38(8):2303-15
18629938
Comp Med. 2008 Aug;58(4):389-94
18724782
Curr Opin Immunol. 2007 Apr;19(2):209-16
17276050
J Biochem. 1994 Mar;115(3):381-6
8056746
Curr Gene Ther. 2007 Oct;7(5):316-24
17979678
FASEB J. 2006 Oct;20(12):1964-73
17012248
Glycobiology. 2004 Apr;14(4):339-46
14693915
Immunogenetics. 2009 May;61(5):401-17
19337729
Biochem J. 1989 Oct 15;263(2):355-63
2556992
Curr Opin Struct Biol. 2009 Oct;19(5):507-14
19699080
Nature. 2007 Apr 26;446(7139):1023-9
17460663
Blood. 2009 Dec 10;114(25):5225-35
19828701
J Immunol. 2000 May 1;164(9):4742-51
10779780
Q Rev Biol. 2004 Mar;79(1):3-50
15101252
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13251-6
15331780
J Cell Biol. 1992 Feb;116(4):901-9
1310320
Nat Rev Immunol. 2005 Mar;5(3):201-14
15719024
Glycoconj J. 2006 Feb;23(1-2):51-8
16575522
Glycobiology. 2006 Jan;16(1):1R-27R
16014749
Cancer Res. 2006 Mar 15;66(6):2937-45
16540641
Science. 2005 Sep 9;309(5741):1693
16151003
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11751-6
9751737
Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1718-24
19966301
Microbiol Mol Biol Rev. 2004 Mar;68(1):132-53
15007099
Nature. 2008 Dec 4;456(7222):648-52
18971931
J Virol. 2000 Dec;74(24):11825-31
11090182
Am J Epidemiol. 2009 Apr 1;169(7):867-76
19234096
Nat Rev Immunol. 2007 Apr;7(4):255-66
17380156
Neurosci Lett. 2005 Jan 10;373(2):159-64
15567573
J Biol Chem. 1998 Jun 19;273(25):15866-71
9624188
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11399-404
11562455
Int Arch Allergy Appl Immunol. 1978;57(5):477-80
78906
J Infect Dis. 1986 Aug;154(2):370-1
3722870